Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Diabetes Care 30:306-311, 2007
DOI: 10.2337/dc06-1184
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shultis, W. A.
Right arrow Articles by Nelson, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shultis, W. A.
Right arrow Articles by Nelson, R. G.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Pathophysiology/Complications
Original Article

Effect of Periodontitis on Overt Nephropathy and End-Stage Renal Disease in Type 2 Diabetes

Wendy A. Shultis, PHD1, E. Jennifer Weil, MD1, Helen C. Looker, MBBS1, Jeffrey M. Curtis, MD, MPH1, Marc Shlossman, DDS, MS2,3, Robert J. Genco, DDS, PHD2, William C. Knowler, MD, DRPH1 and Robert G. Nelson, MD, PHD1

1 Diabetes Epidemiology and Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona
2 Department of Oral Biology, State University of New York at Buffalo, Buffalo, New York
3 Arizona School of Dentistry and Oral Health, Mesa, Arizona

Address correspondence and reprint requests to Dr. Wendy A. Shultis, National Institutes of Health, 1550 E. Indian School Rd., Phoenix, AZ 85014-4972. E-mail: shultisw{at}mail.nih.gov

OBJECTIVE—The purpose of this study was to investigate the effect of periodontitis on development of overt nephropathy, defined as macroalbuminuria, and end-stage renal disease (ESRD) in type 2 diabetes.

RESEARCH DESIGN AND METHODS—Individuals residing in the Gila River Indian Community aged ≥25 years with type 2 diabetes, one or more periodontal examination, estimated glomerular filtration rate ≥60 ml/min per 1.73 m2, and no macroalbuminuria (urinary albumin-to-creatinine ratio ≥300 mg/g) were identified. Periodontitis was classified as none/mild, moderate, severe, or edentulous using number of teeth and alveolar bone score. Subjects were followed to development of macroalbuminuria or ESRD, defined as onset of renal replacement therapy or death attributed to diabetic nephropathy.

RESULTS—Of the 529 individuals, 107 (20%) had none/mild periodontitis, 200 (38%) had moderate periodontitis, 117 (22%) had severe periodontitis, and 105 (20%) were edentulous at baseline. During follow-up of up to 22 years, 193 individuals developed macroalbuminuria and 68 developed ESRD. Age- and sex-adjusted incidence of macroalbuminuria and ESRD increased with severity of periodontitis. After adjustment for age, sex, diabetes duration, BMI, and smoking in a proportional hazards model, the incidences of macroalbuminuria were 2.0, 2.1, and 2.6 times as high in individuals with moderate or severe periodontitis or those who were edentulous, respectively, compared with those with none/mild periodontitis (P = 0.01). Incidences of ESRD in individuals with moderate or severe periodontitis or in those who were edentulous were 2.3, 3.5, and 4.9 times as high, respectively, compared with those with none/mild periodontitis (P = 0.02).

CONCLUSIONS—Periodontitis predicts development of overt nephropathy and ESRD in individuals with type 2 diabetes. Whether treatment of periodontitis will reduce the risk of diabetic kidney disease remains to be determined.

Abbreviations: ACR, albumin-to-creatinine ratio • ARIC, Atherosclerosis Risk in Communities • ESRD, end-stage renal disease • GFR, glomerular filtration rate • MDRD, Modification of Diet in Renal Disease


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Dent. Res.Home page
C.W. Bassim, R.S. Redman, D.J. DeNucci, K.L. Becker, and E.S. Nylen
Salivary Procalcitonin and Periodontitis in Diabetes
J. Dent. Res., July 1, 2008; 87(7): 630 - 634.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
F. N. Varon
Effect of Periodontitis on Overt Nephropathy and End-Stage Renal Disease in Type 2 Diabetes: Response to Shultis et al.
Diabetes Care, December 1, 2007; 30(12): e138 - e138.
[Full Text] [PDF]


Home page
Diabetes CareHome page
W. A. Shultis, E. J. Weil, H. C. Looker, J. M. Curtis, M. Shlossman, R. J. Genco, W. C. Knowler, and R. G. Nelson
Effect of Periodontitis on Overt Nephropathy and End-Stage Renal Disease in Type 2 Diabetes: Response to Varon
Diabetes Care, December 1, 2007; 30(12): e139 - e139.
[Full Text] [PDF]


Home page
DOC NewsHome page
K. New
To Predict Diabetic Nephropathy, First Look at Gums
DOC News, May 1, 2007; 4(5): 10 - 10.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.